Topspin Fund L.P. 13D and 13G filings for NGM Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-11-20 4:36 pm Sale | 2020-11-20 | 13G | NGM Biopharmaceuticals, Inc. NGM | Topspin Fund L.P. | 3,320,498 4.800% | -1,512,836![]() (-31.30%) | Filing |